| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | Chan Henry Lee | SVP, General Counsel | Aug 13, 2025 | Option/RSU Exercise | $177.90 | 8,230 | 1,464,080 | 8,230 | Aug 15, 2025, 04:38 PM | |
| ONC | BeOne Medicines Ltd. | Chan Henry Lee | SVP, General Counsel | Aug 13, 2025 | Sale | $300.45 | 11,013 | 3,308,877 | 2,178 | Aug 15, 2025, 04:38 PM | |
| ONC | BeOne Medicines Ltd. | Chan Henry Lee | SVP, General Counsel | Jul 30, 2025 | Sale | $304.60 | 920 | 280,233 | 0 | Jul 31, 2025, 05:04 PM | |
| ONC | BeOne Medicines Ltd. | Chan Henry Lee | SVP, General Counsel | Jun 16, 2025 | Sale | $266.50 | 422 | 112,463 | 0 | Jun 18, 2025, 05:12 PM | |
| ONC | BeOne Medicines Ltd. | Chan Henry Lee | SVP, General Counsel | Jun 06, 2025 | Sale | $256.11 | 700 | 179,280 | 230 | Jun 10, 2025, 04:57 PM | |
| BGNE | BeiGene, Ltd. | Chan Henry Lee | SVP, General Counsel | Feb 27, 2025 | Sale | $275.00 | 1,205 | 331,375 | 0 | Mar 03, 2025, 04:49 PM | |
| BGNE | BeiGene, Ltd. | Chan Henry Lee | SVP, General Counsel | Feb 21, 2025 | Sale | $258.04 | 1,202 | 310,170 | 698 | Feb 25, 2025, 05:04 PM | |
| BGNE | BeiGene, Ltd. | Chan Henry Lee | SVP, General Counsel | Sep 30, 2024 | Sale | $237.10 | 1,202 | 284,994 | 0 | Oct 02, 2024, 07:13 PM | |
| BGNE | BeiGene, Ltd. | Chan Henry Lee | SVP, General Counsel | Jul 30, 2024 | Sale | $160.57 | 834 | 133,915 | 0 | Aug 01, 2024, 05:06 PM | |
| BGNE | BeiGene, Ltd. | Chan Henry Lee | SVP, General Counsel | Jun 17, 2024 | Sale | $159.35 | 439 | 69,955 | 337 | Jun 20, 2024, 05:24 PM | |
| BGNE | BeiGene, Ltd. | Chan Henry Lee | SVP, General Counsel | Jul 31, 2023 | Sale | $216.26 | 791 | 171,059 | 0 | Aug 02, 2023, 05:10 PM |